"A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of BR6002 and Coadministration of BR6002A and BR6002B Under Fasting Conditions in Healthy Adult Volunteers"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

August 24, 2023

Study Completion Date

August 24, 2023

Conditions

Gastric or Duodenal Ulcers

Interventions

DRUG

BR6002A

One tablet administered alone

DRUG

BR6002B

One tablet administered alone

DRUG

BR6002

One capsule administered alone

Trial Locations (1)

Clinical Research Center, H PLUS Yangji Hospital, Seoul